Načítá se...
ADRB2 Polymorphisms and Budesonide/Formoterol Responses in COPD
BACKGROUND: Effects of β(2)-adrenergic receptor gene (ADRB2) polymorphism on therapeutic responses to long-acting β(2)-adrenergic agonists have not been evaluated in long-term COPD trials. We aimed to investigate the effects of the ADRB2 Gly16Arg polymorphism on response to formoterol alone or in co...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American College of Chest Physicians
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3425335/ https://ncbi.nlm.nih.gov/pubmed/22383665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.11-1655 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|